Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma
Autore:
Mohiuddin, M; Cao, XB; Fang, BL; Nishizaki, M; Smythe, WR;
Indirizzi:
Univ Texas, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA Univ Texas Houston TX USA 77030 t Thorac Mol Oncol, Houston, TX 77030 USA
Titolo Testata:
CANCER GENE THERAPY
fascicolo: 8, volume: 8, anno: 2001,
pagine: 547 - 554
SICI:
0929-1903(200108)8:8<547:SAOPGT>2.0.ZU;2-O
Fonte:
ISI
Lingua:
ENG
Soggetto:
MALIGNANT PLEURAL MESOTHELIOMA; BUTYRATE-INDUCED APOPTOSIS; SODIUM-BUTYRATE; LUNG-CANCER; HISTONE DEACETYLASE; MEDIATED APOPTOSIS; IN-VITRO; CELLS; ADENOVIRUS; EXPRESSION;
Keywords:
bcl-2; bcl-xl; bax; bak; p53; gene therapy; sodium butyrate; mesothelioma;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
37
Recensione:
Indirizzi per estratti:
Indirizzo: Smythe, WR Univ Texas, MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, 1515 Holcombe Blvd,Box 109, Houston, TX 77030 USA Univ Texas 1515 Holcombe Blvd,Box 109 Houston TX USA 77030 USA
Citazione:
M. Mohiuddin et al., "Significant augmentation of pro-apoptotic gene therapy by pharmacologic bcl-xl down-regulation in mesothelioma", CANC GENE T, 8(8), 2001, pp. 547-554

Abstract

The ratio of pro-apoptotic (PAP) and anti-apoptotic (AAP) bcl-2 proteins, is important in apoptosis regulation. We sought to determine if inhibition of the AAP bcl-xl by sodium butyrate (SB) would augment apoptotic cellular death in mesothelioma when combined with adenoviral pro-apoptotic gene therapy (PAGT) by simultaneously increasing PAP and decreasing AAP in these cells. Human mesothelioma cell lines were exposed to AdBax, AdBak, Adp53, and SB alone as well as all vectors combined with SB at varying doses and time points. Cell death was assessed, and apoptosis evaluated by morphology and FACS. Isobologram analysis evaluated additive or synergistic effect. Cellular death and apoptosis were augmented by PAGT/SB combinations compared to monotherapy. Following AdBax/SB and AdBak/SB, a decrease of the AAP bcl-xl was noted in combination with increases in PAP bax and bak. By isobologram analysis, additive or synergistic cell killing was noted with both combinations. SB treatment did not significantly augment cell killing or apoptosis in combination with Adp53. PAGT/SB was more effective than monotherapy in induction of apoptotic cell death. Synergy may be due to the ability of SB todecrease bcl-xl with marked increases in PAP engendered by PAGT. Combination therapy with agents that down-regulate AAP in addition to PAGT may proveuseful clinically.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 15:00:52